<DOC>
	<DOCNO>NCT02314429</DOCNO>
	<brief_summary>In first-in-human volunteer phase I clinical trial , vaginal ring slowly release lactic acid ( racemic mixture ) vaginal environment , insert healthy volunteer woman leave place 7 day . The primary objective phase I study assess safety tolerability new intravaginal delivery system . The eventual goal related study develop vaginal ring reduces recurrence woman suffer bacterial vaginosis , common form vaginal infection .</brief_summary>
	<brief_title>Trial Evaluating Safety Lactate Releasing Vaginal Ring Prophylaxis Bacterial Vaginosis</brief_title>
	<detailed_description />
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<criteria>Good general physical mental health Presence normal ( lactobacillidominated ) vaginal microbiota Prepared take oral contraception study Pregnancy Lactation Systemic disease Menopause Recent use antibiotic ( &lt; 1 week enter study ) Recent use intravaginal product device ( &lt; 1 week enrolment ) Presence vaginal infection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>